Tag: Drug supply chain

Following unprecedented demand, Eli Lilly resolved the widespread Zepbound shortage by investing billions in manufacturing expansions and strategic supply chain initiatives. This ultimately led the FDA to declare the tirzepatide supply issues resolved by December 2024.

According to a September 2025 report from the American Society of Health-System Pharmacists (ASHP), several manufacturers of acetazolamide injection have reported shortages. The question, **"Is acetazolamide out of stock?"** has therefore become a pressing concern for patients and healthcare providers relying on this medication for conditions like glaucoma, altitude sickness, and heart failure. This article provides a comprehensive overview of the current supply issues, including which formulations are affected and what alternatives might be available.

Studies have shown that implementing systematic inventory management strategies, such as combining Economic Order Quantity (EOQ) and Vital, Essential, Desirable (VED) analysis, can significantly improve efficiency and reduce costs in pharmaceutical distribution. These inventory control models are fundamental for pharmacy professionals to ensure the right amount of medication is available at the right time, balancing financial prudence with patient care.

An estimated 83% of independent pharmacies in the U.S. contracted with a Pharmacy Services Administrative Organization (PSAO) in 2019, highlighting their critical role in the complex healthcare landscape. This guide explains what is a PSAO, its essential functions, and how it empowers independent pharmacists to thrive in an increasingly competitive market.